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Primacy of (hypo) mania in the postpartum period: a concept worth considering

The traditional system of classifying postpartum psychiatric disorders into maternity blues,
postpartum depression, and puerperal psychosis overlooks the clinical significance of
hypomanic, manic, or mixed symptoms in the postpartum period. Although common after
childbirth, episodes of hypomania or non-psychotic mania, as well as mixed states, are generally
not included in the traditional nomenclature. The Diagnostic and Statistical Manual of Mental
Disorders (DSM) first acknowledged the role of childbirth in the triggering of manic episodes 25
years ago with the publication of its fourth edition. The official recognition that episodes of
hypomania can occur during or after pregnancy came in 2013 with the publication of DSM-5.
Unfortunately, this endorsement by the DSM has not resulted in increased awareness of the
common occurrence of hypomania or mania during the postpartum period.
In the nineteenth century, mania was a common diagnosis among women hospitalized after
childbirth. In his classic text Traite de la folie des femmes enceintes, des nouvelles accouchees et
des nourrices, Marcé reported 44 cases of puerperal psychosis, of which 29 were of mania.1 He
was the first to recognize mixed states during the puerperal and postpartum disorders: “…we find
in the puerperal state a small number of mixed states that are impossible to classify or to clearly
define...” In the book Mental Maladies: A treatise on insanity, Esquirol noted that 49 out of 92
women with severe postpartum psychiatric illness suffered from mania. Macleod made a
distinction between cases that arise early and those that appear late in the postpartum period.
Cases occurring early in the postpartum period were likely to have “excitatory or manic
qualities” in contrast to the melancholic cases that generally but not always occurred later in the
postpartum period. With the beginning of deinstitutionalization in the 1960s, the focus started
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shifting from severe mental illnesses, such as mania or melancholia, to the study of more
common postpartum clinical entities, such as the maternity blues and mild depression. The
waning of interest in postpartum mania seems to have coincided with the discovery of
antidepressants in the 1950s. Common usage of the term “puerperal psychosis” to capture cases
of mania with or without psychotic features also resulted in lack of interest in the study of
postpartum mania.
In women with bipolar disorder, postpartum mood episodes should be easily preventable because
at-risk women can be easily identified, the nature of the trigger is known, and the risk period for
occurrence of mood episodes is short. However, studies have found high rates of recurrence of
mood episodes—particularly depression—despite the prophylactic use of pharmacotherapy.
Although sparse in nature, the extant literature on the acute or prophylactic treatment of
postpartum mood disorders has demonstrated that medications are not particularly effective in
reducing the depression morbidity after delivery. In spite of prophylactic treatment, women with
bipolar disorder are at high risk for recurrence of mood or psychotic episodes in the postpartum
period. A large study from the United States and Italy found that 52% of women with bipolar I or
II disorder had recurrence of a mood or anxiety episode during the first 6 months postpartum.2
The primacy of mania hypothesis was proposed by Dr. Athanasios Koukopoulos. The primary
empirical predictions based on the hypothesis are outlined in Panel 1. According to the
hypothesis, manic and depressive states are intrinsically linked, and depression is a consequence
of manic states. The connectedness of manic symptoms and depression is best exemplified by
mixed states. In this context, the term “mania” includes not only episodic euphoria plus
hyperactivity, but it encompasses a wide range of excitatory symptoms including irritability,
psychomotor agitation and distractibility. Thus, the prevention or treatment of excitatory
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behaviors that characterize mania should result in the prevention of ensuing depression.
Moreover, the use of antidepressants in patients with mixed episodes would be ineffective or
would lead to mood instability.3
According to a recent systematic review, 9.6-49.1% of women have hypomanic symptoms after
delivery. Of women referred to speciality clinics, 12-30% reported experiencing hypomanic or
manic symptoms after childbirth.4 We argue that the primacy of (hypo) mania concept may be
particularly relevant in the postpartum period due to the common occurrence of
hypomanic/manic symptoms.2,4 Specifically, treatment approaches emphasizing prevention of
hypomania or mania may be more effective in reducing postpartum morbidity and promoting
safety in women with bipolar disorder.

Diagnostic and treatment implications
Over the last few decades, unipolar postpartum depression has been the focus of major research
inquiry. Due to the increased awareness of associated morbidity and mortality, and of its
deleterious effects on child health and development, women are more likely to be screened for
depression than for hypomanic or manic symptoms. The common knowledge of available
treatments, including antidepressants and psychotherapy, has made it easier for women to seek
help for depression in the postpartum period. Despite clear guidance from major classification
manuals that women with major depressive disorder or bipolar disorder can experience a
depressive episode in the postpartum period, the term postpartum depression has become
synonymous with unipolar postpartum depression.
Our emphasis on the detection and management of hypomania or mania to prevent postpartum
depression is a paradigm shift from how postpartum mood disorders are currently assessed and
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managed. Unless asked specifically, women do not generally report symptoms of postpartum
hypomania or mania. Clinicians may focus solely on unipolar depression and not ask pertinent
questions to clarify the bipolar diathesis of postpartum depression. Episodes of hypomania can
be easily missed because they are generally not severe enough to cause marked social or
occupational impairment, or necessitate hospital admission. Moreover, it can be difficult to
distinguish between symptoms of hypomania and normal elation accompanying the birth of a
child.
Major depressive disorder with mixed features (mixed depression), generally considered a prebipolar condition, first appeared as a diagnostic entity in the DSM-5. The DSM-5 allows the use
of the mixed features specifier to characterize a current mood episode in the context of bipolar I,
bipolar II, or major depressive disorder. At least three hypomanic or manic symptoms that do not
overlap with symptoms of a major depressive episode are required for application of the mixed
features specifier in patients with major depressive disorder. According to the primacy of (hypo)
mania hypothesis, antidepressants should play a limited role in the management of postpartum
mood disorders and should only be considered in women with non-mixed depression.
Despite the paucity of controlled data on their efficacy, antidepressants are commonly prescribed
for the acute and preventative treatment of postpartum depression. Due to their ease of use and
reduced liability for weight gain, clinicians may be more comfortable prescribing antidepressants
than atypical neuroleptics or other mood stabilizers. Women with a bipolar diathesis may be
more agreeable to try selective serotonin reuptake inhibiting antidepressants because these drugs
are perceived as less stigmatizing than atypical antipsychotics or mood stabilizers.
A personalized and targeted approach to pharmacotherapy of postpartum mood disorders, guided
by the primacy of (hypo) mania hypothesis, may reduce the need for polypharmacy and lessen
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side effect burden. Given the frequency of hypomanic or manic symptoms immediately
following delivery and their association with postpartum depression, strategies aimed at
prevention or treatment of these symptoms may be more effective in preventing episodes of
depression. Drug treatment of hypomania is generally not recommended unless symptoms are
severe or functionally impairing; however, the prevention or treatment of these symptoms may
be effective in preventing episodes of postpartum depression. Similarly, mood stabilizers and
atypical neuroleptics may be better choices than antidepressants in the treatment of mixed
depression after delivery since antidepressants may be ineffective or may exacerbate
subthreshold manic symptoms.

Limitations
A major limitation of the primacy of (hypo) mania hypothesis is that it has not been tested in the
postpartum population. In fact, this concept is not very popular even among researchers in the
bipolar field. Given the reasons outlined in this article we believe that the primacy of (hypo)
mania hypothesis may be particularly relevant in the postpartum period. Episodes of hypomania
or mania do not always precede or co-occur with episodes of depression. Symptoms of
hypomania can be difficult to detect in the postpartum period, particularly among women with
no prior history of these symptoms. Also, a large number of women do not receive an accurate
diagnosis of bipolar disorder before they have children and hence may not be referred for
psychiatric care during or after pregnancy.

Future research
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It is hoped that the proposed reconceptualization of postpartum mood disorders would stimulate
research on alternate ways of assessing and treating postpartum mood disorders. The postpartum
period should provide a remarkable opportunity to test the validity of the primacy of (hypo)
mania hypothesis because symptoms of hypomania or mania are common after delivery and they
usually precede rather than follow postpartum depression. Moreover, the time interval between
the end of hypomania or mania and ensuing depression is generally short, which should make it
easier to assess the impact of acute and preventative treatment strategies in postpartum mood
disorders.
Currently, there are no studies on the potential effect of polarity of first onset on the sequence of
mood episodes in the postpartum period.5 Such studies should provide crucial information to
facilitate the early identification of women who develop hypomanic or manic episodes
immediately after delivery, and therefore permit the implementation of a personalized treatment
approach to prevent mood episodes. Studies using alternate drugs such as mood stabilizers or
atypical neuroleptics are urgently needed given the limited evidence of antidepressant efficacy in
the acute treatment of unipolar postpartum depression. Knowledge of the timing of onset of
mood episodes (pregnancy vs. postpartum) and the nature of subthreshold symptoms preceding
mood episodes is necessary for implementation of effective prophylactic interventions.
Similarly, there are no psychotherapeutic studies in the prevention of bipolar disorder in the
postpartum period. According to the primacy of (hypo) mania hypothesis, psychotherapeutic
strategies aimed at prevention of hypomania or mania may be effective in preventing depression.
Circadian rhythm disruptions are particularly common in the postpartum period and may play a
crucial role in triggering or exacerbating mood episodes in women with bipolar disorder. Thus
the prophylactic use of interpersonal and social rhythm therapy—due to its emphasis on
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promoting sleep—may be particularly effective in preventing subthreshold hypomanic or manic
symptoms and therefore depression.
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Panel 1: Empirical predictions based on the primacy of (hypo) mania hypothesis
___________________________________________________________________
1. There will be a shorter interval between the end of a manic episode and the onset of
the next depressive episode compared to the interval between the end of a depressive
episode and the onset of the next manic episode.
2. Mood stabilizers will be more effective in preventing mood episodes if started during
a euthymic interval rather than during a manic episode.
3. Mood stabilizers will be ineffective (compared to placebo) in the treatment of pure
depressive episodes (i.e., depressive episodes without concomitant hypomanic or
manic symptoms).
4. Antidepressants will be ineffective in the treatment of depressive mixed states;
conversely, mood stabilizers will be effective in these mood states.
5. Mood stabilizers will be more effective than antidepressants in the prevention of
episodes of unipolar as well as bipolar depression.

